NACDS Hails Bipartisan Congressional Momentum for PBM Reform
NACDS to the U.S. Congress: Enact the full array of reforms on which bipartisan consensus has been achieved
NACDS to the U.S. Congress: Enact the full array of reforms on which bipartisan consensus has been achieved
California patients and providers urge Gov. Newsom to sign SB 966, PBM reform legislation
California Senate Bill 966 would help rein in the harmful tactics of the PBM middlemen by providing much-needed oversight and transparency.
NACDS: “Given the intolerable nature of market-dominant PBMs’ practices and their far-reaching negative effects, the reforms that now enjoy bipartisan and bicameral consensus must be considered ‘must-pass’ legislation in the 118th Congress”
NACDS’ seven-figure ad campaign to advance PBM reform will reach Presidential debate viewers in the Washington, D.C. market this week.
2024 NACDS Total Store Expo welcomes NACDS chain and supplier members to Boston with impressive conference schedule; opportunities to come together to collaborate, innovate and confront industry pressures.
NACDS continues to urge the vital need for reforms at the federal level that will prevent “pharmaceutical benefit manipulation” across all markets – Medicare, Medicaid and commercial.
Report: “The Committee’s findings indicate that the present role of PBMs in prescription drug markets is failing and requires change”
NACDS urges “tenacity” by House Oversight and Accountability Committee in its hearing and investigation.
A coalition of organizations representing pharmacies and pharmacists across all practice settings released a statement today ahead of a Tuesday, July 23 U.S. House Committee on Oversight and Accountability hearing on PBM middlemen tactics.